Nutritional supplements contain vitamins and minerals that are essential for the body to maintain good health. In recent years, the use of nutritional supplements has been considered because of the growing prevalence of unhealthy lifestyle.
In this area, efforts are made to comprehensively study and treat properly the different types of wounds. One of the effective activities in this field is the development of new dressings based on the science of biotechnology, which accelerate the healing of various wounds.
It includes inflammatory and autoimmune diseases affecting the musculoskeletal system. These complications can also affect other organs in the body, such as blood vessels, skin, nerves, and many internal organs, and this adds to their importance.
The recombinant Papilloguard vaccine contains virus-like particles that are used to prevent cancers caused by the human papillomavirus (HPV).
Dyston is a brand name of Clostridium botulinum type A toxin that has wide applications in medicine and beauty.
Beraksurf is a natural lung surfactant used to treat and prevent neonatal respiratory distress syndrome (RDS).
PerkinRA, the brand name of Anakinra, is used to treat the autoimmune disease of juvenile systemic rheumatoid arthritis as well as infectious diseases.
Amniodisk is an allograft tissue of the human amniotic membrane that is used to repair wounds and corneal injuries.
bFGF serum contains active decapeptide derived from fibroblast growth factor (bFGF), which is involved in the control of vitiligo.
Colostrum is the richest milk produced by female mammals in the first few days after birth, which is full of immune, growth and tissue repair factors.
SamFit is a natural supplement for athletes made from colostrum. Colostrum is the richest milk produced by mammals.
Algofill is the brand name of the microalgae Chlorella vulgaris, which has biological and medicinal properties for human health.
Cell-amniosin is a frozen biological cell-containing coating that has analgesic properties and prevents scarring and scarring.
Immunogenicity and safety of a bivalent, adjuvant system 04–adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15–25: a randomized, double-blind, phase III, noninferiority clinical trial